Gateways for Glutamate Neuroprotection in Parkinson’s Disease (PD): Essential Role of EAAT3 and NCX1 Revealed in an In Vitro Model of PD
Autor: | Alessandra Preziuso, Silvia Piccirillo, Salvatore Amoroso, Pasqualina Castaldo, Simona Magi, Vincenzo Lariccia |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
Parkinson's disease
EAAT3 Retinoic acid Glutamic Acid glutamate Pharmacology Transfection Neuroprotection Article Sodium-Calcium Exchanger chemistry.chemical_compound Cell Line Tumor mitochondrial dysfunction medicine Humans lcsh:QH301-705.5 Cell damage NCX1 Chemistry neuronal survival Dopaminergic Glutamate receptor Parkinson Disease General Medicine Rotenone medicine.disease Excitatory Amino Acid Transporter 3 lcsh:Biology (General) Parkinson’s disease Reperfusion injury |
Zdroj: | Cells Volume 9 Issue 9 Cells, Vol 9, Iss 2037, p 2037 (2020) |
ISSN: | 2073-4409 |
DOI: | 10.3390/cells9092037 |
Popis: | Increasing evidence suggests that metabolic alterations may be etiologically linked to neurodegenerative disorders such as Parkinson&rsquo s disease (PD) and in particular empathizes the possibility of targeting mitochondrial dysfunctions to improve PD progression. Under different pathological conditions (i.e., cardiac and neuronal ischemia/reperfusion injury), we showed that supplementation of energetic substrates like glutamate exerts a protective role by preserving mitochondrial functions and enhancing ATP synthesis through a mechanism involving the Na+-dependent excitatory amino acid transporters (EAATs) and the Na+/Ca2+ exchanger (NCX). In this study, we investigated whether a similar approach aimed at promoting glutamate metabolism would be also beneficial against cell damage in an in vitro PD-like model. In retinoic acid (RA)-differentiated SH-SY5Y cells challenged with &alpha synuclein (&alpha syn) plus rotenone (Rot), glutamate significantly improved cell viability by increasing ATP levels, reducing oxidative damage and cytosolic and mitochondrial Ca2+ overload. Glutamate benefits were strikingly lost when either EAAT3 or NCX1 expression was knocked down by RNA silencing. Overall, our results open the possibility of targeting EAAT3/NCX1 functions to limit PD pathology by simultaneously favoring glutamate uptake and metabolic use in dopaminergic neurons. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |